Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

Peisen, Felix; Gerken, Annika; Hering, Alessa; Dahm, Isabel; Nikolaou, Konstantin; Gatidis, Sergios; Eigentler, Thomas K.; Amaral, Teresa; Moltz, Jan H.; Othman, Ahmed E.

dc.contributor.author	Dahm, Isabel
dc.contributor.author	Nikolaou, Konstantin
dc.contributor.author	Gatidis, Sergios
dc.contributor.author	Amaral, Teresa
dc.contributor.author	Peisen, Felix Ludwig
dc.contributor.author	Eigentler, Thomas
dc.date.accessioned	2024-11-19T11:00:00Z
dc.date.available	2024-11-19T11:00:00Z
dc.date.issued	2024
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/158978
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers16152669	de_DE
dc.subject.ddc	610	de_DE
dc.title	Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_00563
utue.personen.roh	Peisen, Felix
utue.personen.roh	Gerken, Annika
utue.personen.roh	Hering, Alessa
utue.personen.roh	Dahm, Isabel
utue.personen.roh	Nikolaou, Konstantin
utue.personen.roh	Gatidis, Sergios
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Moltz, Jan H.
utue.personen.roh	Othman, Ahmed E.
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 2669	de_DE
dcterms.isPartOf.ZS-Volume	16 (15)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE